LAMISIL AF by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Drug facts, warnings, and ingredients follow.
LAMISIL AF DEFENSE- tolnaftate aerosol, spray
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
For external use only
Flammability Warning: Contents under pressure. Do not puncture or incinerate. Flammable mixture; do not use near fire or flame, or expose to heat or temperature above 490C (1200F). Use only as directed. Intentional misuse by deliberately concentrating and inhaling contents can be harmful or fatal.
aluminum starch octenyl succinate, fragrance, isopropyl myristate, propylene carbonate, SD alcohol 40-B (11%w/w), sorbitan oleate, stearalkonium hectorite, talc
Propellant: isobutane, propane
Distributed by:
GSK Consumer Healthcare,Warren, NJ 07059GSK Consumer Healthcare, Warren, NJ 0705
©2016 GSK group of companies or its licensor. All rights reserved.
www.lamisil.com
10002
DOT-2P
M5735
NDC: 0067-6114-46
TOLNAFTATE 1% - ANTIFUNGAL
LAMISILAF
DEFENSE®
SPRAY POWDER
PREVENTS MOST ATHLETE’S FOOT
ABSORBS WETNESS
CURES MOST ATHLETE’S FOOT
NET WT. 4.6 oz (133 g)
LAMISIL AF
DEFENSE
tolnaftate aerosol, spray |
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263) |